Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-062945
Filing Date
2025-05-02
Accepted
2025-05-02 17:23:44
Documents
1
Period of Report
2025-05-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3871
  Complete submission text file 0000950170-25-062945.txt   5430
Mailing Address 88 SIDNEY ST CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-494-0171
SCHIMMEL PAUL (Reporting) CIK: 0001236447 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37378 | Film No.: 25910093

Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Issuer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)